Monday, May 2, 2011

Teva Acquires Cephalon for $6.8 Billion

Teva Pharmaceuticals Industries, Ltd., is headquartered in Israel, but has long operated prominently in this area and on Monday it acquired Cephalon, Inc., of Frazer, in a $6.8 billion deal, both companies announced.

Read more at the Philadelphia Inquirer.

No comments:

Post a Comment